Literature DB >> 31683008

Clinical features and phylogenetic analysis of severe hand-foot-and-mouth disease caused by Coxsackievirus A6.

Xiaohan Yang1, Yuanyuan Li2, Changbin Zhang1, Wenli Zhan1, Jia Xie3, Siqi Hu3, Huiying Chai1, Pan Liu1, Hongyu Zhao1, Bin Tang1, Keyi Chen1, Jian Yu4, Aihua Yin1, Mingyong Luo5.   

Abstract

BACKGROUND: Coxsackievirus A6 (CA6) infection may lead to high hand-foot-and-mouth disease (HFMD) aggregation in children. We aimed to analyze the clinical and phylogenetic features of severe CA6-associated pediatric HFMD.
METHODS: The clinical and laboratory features of 206 and 55 children with mild and severe CA6-associated HFMD, respectively, were summarized. The CA6 phylogenetic tree was depicted using combinatorial analysis of the VP1-encoding regions and neighbor-joining method.
RESULTS: CA6 was the major pathogen both in mild and severe HFMD in 2017. Most CA6-associated severe HFMD cases showed high fever, skin rash, age younger than 36 months, and elevated white blood cell and C-reactive protein levels, and there were no significant differences compared to the mild cases (p > 0.05). The severe cases were significantly more likely (p < 0.05) to show male sex, long fever duration, decreased oral intake, tonsil enlargement, diarrhea, vomiting, elevated levels of creatine kinase and blood glucose, and positive fecal occult-blood test results. Severe complications included aseptic meningitis (29/55, 52.7%) and pulmonary edema (6/55, 10.9%) were observed in severe cases. Furthermore, genetic analyses showed all CA6 isolates belonged to lineage E2, and two amino acid changes of V174I and T283A in VP1 may be associated with the severity of HFMD.
CONCLUSIONS: CA6 has become a major cause of HFMD with severe systemic disorders. V174I and T283A of VP1 may be associated with the severity of CA6 infection. These findings could raise awareness of the clinical importance of CA6 infection among practitioners.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coxsackievirus A6; Etiology; Hand-foot-and-mouth disease; Phylogenetic analysis

Mesh:

Substances:

Year:  2019        PMID: 31683008     DOI: 10.1016/j.meegid.2019.104054

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  12 in total

1.  A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.

Authors:  Zaixue Jiang; Yaozhong Zhang; Huayuan Lin; Qingqiu Cheng; Xiaomei Lu; Wenkuan Liu; Rong Zhou; Baimao Zhong; Xingui Tian
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

2.  Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.

Authors:  Nieves Martínez-López; Carmen Muñoz-Almagro; Cristian Launes; Ana Navascués; Manuel Imaz-Pérez; Jordi Reina; María Pilar Romero; Cristina Calvo; Montserrat Ruiz-García; Gregoria Megias; Juan Valencia-Ramos; Almudena Otero; María Cabrerizo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

3.  Regional-level risk factors for severe hand-foot-and-mouth disease: an ecological study from mainland China.

Authors:  Qing Pan; Fengfeng Liu; Juying Zhang; Xing Zhao; Yifan Hu; Chaonan Fan; Fan Yang; Zhaorui Chang; Xiong Xiao
Journal:  Environ Health Prev Med       Date:  2021-01-08       Impact factor: 3.674

Review 4.  Secondary hypogonadism following hand, foot, and mouth disease in an adult: a case report and review of literature.

Authors:  Zhaoying Chen; Chen Jiang; Xiaoyu Cheng; Lidan Ma; Ying Xin; Tian Liu; Ruixia Sun
Journal:  BMC Infect Dis       Date:  2022-01-15       Impact factor: 3.090

5.  Coxsackievirus A6 strains causing an outbreak of hand-foot-and-mouth disease in Northeastern Brazil in 2018.

Authors:  Adriana Luchs; Lais Sampaio de Azevedo; Ellen Viana de Souza; Roberta Salzone Medeiros; Yasmin França Viana Pires de Souza; Dalane Loudal Florentino Teixeira; Thiago Franco de Oliveira Carneiro; Gabriela Maria Fernandes de Alencar; Fernanda Lúcia de Sousa Leite Morais; Diana de Fátima Alves Pinto; Thelma Suely Okay; Lidia Yamamoto; Vanessa Dos Santos Morais; Emerson Luiz Lima Araújo; Elcio Leal; Antonio Charlys da Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-02-21       Impact factor: 1.846

Review 6.  Aseptic Meningitis in Oral Medicine: Exploring the Key Elements for a Challenging Diagnosis: A Review of the Literature and Two Case Reports.

Authors:  Stefania Leuci; Noemi Coppola; Tiziana Cantile; Elena Calabria; Laurenta Lelia Mihai; Michele Davide Mignogna
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390

7.  Epidemiological characteristics, routine laboratory diagnosis, clinical signs and risk factors for hand, -foot -and -mouth disease: A systematic review and meta-analysis.

Authors:  Zhijie Yi; Shujun Pei; Wenshuai Suo; Xiaoyang Wang; Zengyuan Huang; Aihua Yi; Bohao Wang; Zhiquan He; Ruolin Wang; Yi Li; Wei Fan; Xueyong Huang
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.240

8.  Epidemiology and clinical manifestations of different enterovirus and rhinovirus types show that EV-D68 may still have an impact on severity of respiratory infections.

Authors:  Simon B Larsson; Diana Vracar; Marie Karlsson; Johan Ringlander; Heléne Norder
Journal:  J Med Virol       Date:  2022-04-18       Impact factor: 20.693

9.  Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China.

Authors:  Jia Xie; Xiao-Han Yang; Si-Qi Hu; Wen-Li Zhan; Chang-Bin Zhang; Hong Liu; Hong-Yu Zhao; Hui-Ying Chai; Ke-Yi Chen; Qian-Yi Du; Pan Liu; Ai-Hua Yin; Ming-Yong Luo
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

10.  Molecular epidemiology of enteroviruses associated with severe hand, foot and mouth disease in Shenzhen, China, 2014-2018.

Authors:  Long Chen; Shao-Jian Xu; Xiang-Jie Yao; Hong Yang; Hai-Long Zhang; Jun Meng; Han-Ri Zeng; Xu-He Huang; Ren-Li Zhang; Ya-Qing He
Journal:  Arch Virol       Date:  2020-07-14       Impact factor: 2.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.